Close

Enanta Pharma (ENTA) Reports EC Marketing Clearance Granted to VIEKIRAX + EXVIERA Tabs

January 16, 2015 7:05 AM EST Send to a Friend
Enanta Pharma (NASDAQ: ENTA) announced that the European Commission has granted marketing authorizations for AbbVie’s (NYSE: ABBV) VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login